Clinical Trials Logo

Ectopic Pregnancy clinical trials

View clinical trials related to Ectopic Pregnancy.

Filter by:
  • Recruiting  
  • Page 1

NCT ID: NCT06354439 Recruiting - Ectopic Pregnancy Clinical Trials

Use of Letrozole for Ectopic Pregnancy

EcZOL
Start date: March 27, 2024
Phase: Phase 4
Study type: Interventional

A randomized clinical trial using oral letrozole 10mg/day for 7 days, for treating early cases of ectopic pregnancy, compared to intramuscular methotrexate

NCT ID: NCT05374720 Recruiting - Hysterectomy Clinical Trials

Analysis of the Molecular Composition of Tubal Cilia in Patients With or Without Ectopic Pregnancy

CILTUBE
Start date: October 1, 2022
Phase: N/A
Study type: Interventional

Primary Ciliary Dyskinesia associated with abnormalities of lateralization of organs (with existence of a situs inversus in 50% of cases) and secondary fertility disorders related in humans to abnormalities of mobility of sperm but very little data on the structure and function of tubal cilia in women

NCT ID: NCT05136274 Recruiting - Ectopic Pregnancy Clinical Trials

Evaluation of Ipsilateral Tubal Patency After Conservative Medical or Surgical Treatment.

EENCBE
Start date: August 17, 2021
Phase: N/A
Study type: Interventional

Ectopic Pregnancy is an entity in which a fertilized ovum is implanted outside its normal place, is considered a public health problem worldwide and is one of the main causes of maternal mortality in the first trimester. The availability of high sensitivity methods of detection of gonadotrophins and the use of high resolution transvaginal ultrasonography have allowed an earlier diagnosis of the same, enabling less aggressive treatments such as the use of parenteral MTX, with the intention of avoiding mutilating surgical treatment , preserving the tube and eventually improving future fertility expectations. The surgical treatment is of choice, this can be laparoscopically or by laparotomy. In this case, we need to preserve fertility, the most indicated is linear salpingostomy; In spite of the existence other techniques.

NCT ID: NCT04739956 Recruiting - Anxiety Clinical Trials

Psychological Impact of Pregnancy of Unknown Location

SOUL
Start date: December 2, 2020
Phase:
Study type: Observational

To assess the psychological impact of pregnancy of unknown location (PUL) classification pending a final diagnosis.

NCT ID: NCT04738370 Recruiting - Ectopic Pregnancy Clinical Trials

Assessment of Biomarkers in Pregnancy on Unknown Location and Ectopic Pregnancy

ABPEP
Start date: December 8, 2014
Phase:
Study type: Observational

To further develop the patient care pathway for women classified with a pregnancy of unknown location (PUL) and ectopic pregnancy (EP).

NCT ID: NCT04315779 Recruiting - Ectopic Pregnancy Clinical Trials

Comparison of Two Different Approaches in the Surgical Treatment of Tubal Ectopic Pregnancy

Start date: February 19, 2020
Phase: N/A
Study type: Interventional

In this study we aim to compare conventional laparoscopy and natural orifice transluminal endoscopic surgery in the surgical treatment of ectopic pregnancy. All the patients, with an indication of surgery for ectopic pregnancy, will be asked to participate in this clinical trial. Indication of surgery will be based on clinical findings, ultrasound scans and serum hcg levels. There will be no exclusion criteria. Duration of surgery, successful completion of the operation, intraoperative data and postoperative data will be collected. All the patients will be asked to fill out quality of recovery-40 (QoR-40) questionnaire and 36-item short form health survey (SF-36) before surgery. QoR-40 questionnaire will be repeated 24 hours after surgery and repeated every 24 hours until discharge. SF-36 will be repeated at 1-month follow-up visit. Patients will be also evaluated at postoperative 3-months, and female sexual function index will be asked to be filled-out.

NCT ID: NCT04176549 Recruiting - Ectopic Pregnancy Clinical Trials

Assessment of Biomarkers in Ectopic Pregnancy

AMBER
Start date: November 18, 2019
Phase:
Study type: Observational

To further develop a patient care pathway (incorporating a statistical model which uses the values of biomarkers) in routine clinical practice that will aid the diagnosis and management of women with an ectopic pregnancy.

NCT ID: NCT01860690 Recruiting - Ectopic Pregnancy Clinical Trials

BHCG Level in Day 4,7, in Comparison to Day 10 as an Indicator for Treatment Success

BHCG
Start date: November 2011
Phase: Phase 4
Study type: Interventional

The investigators want to compeer BHCG levels after Methotrexate ( MTX). treatment for Ectopic pregnancy in days 4 and 7 after MTX. to day 10 . The hypothesis is that "BHCG" level in day 10 is the best indicator for treatment success , superior to day 4 and 7 . According to the investigators impression BHCG level rises in days 4 and 7 due to destruction of the trophoblast tissue , and only day 10 is an indicator for treatment success